Statement of Changes in Beneficial Ownership (4)
26 10월 2019 - 6:04AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Jones Paul A. |
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC
[
USNA
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Leadership Dev Officer
|
(Last)
(First)
(Middle)
3838 WEST PARKWAY BLVD. |
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/23/2019
|
(Street)
SALT LAKE CITY, UT 84120
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
10/23/2019
|
|
M
|
|
549
|
A
|
(1)
|
1920
|
D
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code (Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)
|
8. Price of Derivative Security (Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Restricted Stock Units
|
(1)
|
10/23/2019
|
|
A
|
|
|
549
|
(2)
|
(2)
|
Common Stock
|
549
|
$0
|
10145
|
D
|
|
Explanation of Responses:
|
(1)
|
Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
|
(2)
|
On October 23rd, 2017, the reporting person was granted 2,198 restricted stock units, vesting at 25% on each 23rd of October thereafter.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Jones Paul A. 3838 WEST PARKWAY BLVD. SALT LAKE CITY, UT 84120
|
|
|
Chief Leadership Dev Officer
|
|
Signatures
|
Joshua Foukas, as attorney in fact.
|
|
10/25/2019
|
**Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024
11 USANA Products Now Listed on Prestigious Prescribers' Digital Reference® 0년 10월 10일, 2024 (1 주 전) • PR Newswire (US) |
USANA Schedules Third Quarter 2024 Earnings Release and Conference Call 0년 8월 10일, 2024 (2 주 전) • Business Wire |
USANA Executive Chairman Kevin Guest Celebrates Country Music Month, Mental Balance 0년 1월 10일, 2024 (2 주 전) • PR Newswire (US) |
USANA-Sponsored Olympic and Paralympic Athletes Take Home 99 Combined Medals 0년 19월 9일, 2024 (4 주 전) • PR Newswire (US) |
USANA Executive Chairman Kevin Guest Celebrates Entrepreneurs in Today's Business World 0년 3월 9일, 2024 (1 월 전) • PR Newswire (US) |
USANA Launches New, Innovative Skincare and Protein Products Resurfacing Serum and Whey Protein Isolate up the game for USANA 0년 20월 8일, 2024 (2 월 전) • PR Newswire (US) |
Form 4 - Statement of changes in beneficial ownership of securities 0년 15월 8일, 2024 (2 월 전) • Edgar (US Regulatory) |
Form 144 - Report of proposed sale of securities 0년 14월 8일, 2024 (2 월 전) • Edgar (US Regulatory) |
Form 4 - Statement of changes in beneficial ownership of securities 0년 9월 8일, 2024 (2 월 전) • Edgar (US Regulatory) |
Form 10-Q - Quarterly report [Sections 13 or 15(d)] 0년 7월 8일, 2024 (2 월 전) • Edgar (US Regulatory) |
Form 4 - Statement of changes in beneficial ownership of securities 0년 6월 8일, 2024 (2 월 전) • Edgar (US Regulatory) |
Form 4 - Statement of changes in beneficial ownership of securities 0년 6월 8일, 2024 (2 월 전) • Edgar (US Regulatory) |
More Usana Health Sciences Inc News Articles
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.